Literature DB >> 15704156

Parental occupation and Ewing's sarcoma: pooled and meta-analysis.

Patricia C Valery1, Gail Williams, Adrian C Sleigh, Elizabeth A Holly, Nancy Kreiger, Chris Bain.   

Abstract

Etiologic data on Ewing's sarcoma family of tumors (ESFT) are limited, with only 5 case-control studies reported. Interesting associations, particularly related to parental occupation, have been noted, but results are somewhat inconsistent. We conducted a pooled analysis of 3 case-control studies to assess the overall associations between parental occupation and ESFT. The pooled analysis provided data on parental occupational exposure on 199 cases of ESFT and 1,451 controls. The pooled odds ratio for the periconception and gestation periods were 2.3 (95% CI = 1.3-4.1) for children whose fathers had worked on farms and 3.9 (95% CI = 1.6-9.9) for those whose mothers had farmed. For the periconception and gestation periods, there was a 3.5-fold increased risk for those with both parents having farmed and a doubling of risk for those with at least one parent having farmed; pattern of increasing risk with increasing number of years of postnatal parental exposure to farms was seen. No other occupational group (or more narrowly defined occupations) had other than minor inconsistent associations with the occurrence of ESFT. In addition, we conducted a meta-analysis of farm occupation (a main risk factor) including all 4 case-control studies that collected required information to consider parental occupation. Results of the meta-analysis were consistent with those from the pooled analysis. This collaborative analysis of available individual data on parental occupation and ESFT in the offspring provides evidence supporting the hypothesis of an association between ESFT and parental occupation in farming. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15704156     DOI: 10.1002/ijc.20933

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Children's Oncology Group's 2013 blueprint for research: epidemiology.

Authors:  Logan G Spector; Julie A Ross; Andrew F Olshan
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

2.  Is There a Predisposition Gene for Ewing's Sarcoma?

Authors:  R L Randall; S L Lessnick; K B Jones; L G Gouw; J E Cummings; L Cannon-Albright; J D Schiffman
Journal:  J Oncol       Date:  2010-03-15       Impact factor: 4.375

Review 3.  Review: Ewing Sarcoma Predisposition.

Authors:  Pablo Gargallo; Yania Yáñez; Antonio Juan; Vanessa Segura; Julia Balaguer; Bárbara Torres; Silves Oltra; Victoria Castel; Adela Cañete
Journal:  Pathol Oncol Res       Date:  2019-10-26       Impact factor: 3.201

4.  Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases.

Authors:  Nicolas Penel; Jessica Grosjean; Yves Marie Robin; Luc Vanseymortier; Stéphanie Clisant; Antoine Adenis
Journal:  Sarcoma       Date:  2008

5.  Retrospective clinicopathological study of malignant bone tumors in children and adolescents in Romania - single center experience.

Authors:  R C Petca; S Gavriliu; G Burnei
Journal:  J Med Life       Date:  2016 Apr-Jun

6.  Clinical and radiographic presentation of pelvic sarcoma in children.

Authors:  Muayad Kadhim; Nariman Abol Oyoun; Richard B Womer; John P Dormans
Journal:  SICOT J       Date:  2018-10-19

7.  Case-control study of paternal occupational exposures and childhood bone tumours and soft-tissue sarcomas in Great Britain, 1962-2010.

Authors:  Gerald M Kendall; Kathryn J Bunch; Charles A Stiller; Timothy J Vincent; Michael F G Murphy
Journal:  Br J Cancer       Date:  2020-02-26       Impact factor: 7.640

8.  Increased risk for other cancers in individuals with Ewing sarcoma and their relatives.

Authors:  Diana Abbott; Schuyler O'Brien; James M Farnham; Erin L Young; Jeffrey Yap; Kevin Jones; Stephen L Lessnick; R Lor Randall; Joshua D Schiffman; Lisa A Cannon-Albright
Journal:  Cancer Med       Date:  2019-10-31       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.